Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Orton Pharma Solutions Ltdand Dragon Sail Pharmaceutical Shanghai Co Ltd a subsidiary of Guilin Sanjin hereinafter referred to as Dragon Sail Pharmaceutical formally signed a strategic cooperation agreement in Guilin southern of China This collaborat...
A research led by Hong Kong Baptist University HKBU and the Shanghai Sixth Peoples Hospital Affiliated to School of Medicine at Shanghai Jiao Tong University Shanghai Sixth Peoples Hospital has discovered that an aptamer developed
OBI Pharma Inca clinicalstage global oncology company specialized in the development of novel cancer therapies such as antibodydrug conjugates ADC and active immunotherapies TWO and GlyTech Inc GlyTech a Japan manufacturer that focuses on glycan pro...
CStone Pharmaceuticals an innovationdriven biopharmaceutical company focused on the research and development of anticancer therapies announced today the submission of clinical trial application in Australia for CS
Cytokinetics Incorporated today announced that Sanofi will acquire exclusive rights to develop and commercialize aficamten from Corxel Pharmaceuticals CORXEL for the treatment of patients with obstructive
Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of oncology cardiovascular and metabolic autoimmune
PreneticsIM a premium supplements brand focused on sciencedriven health solutions is excited to announce a collaboration through a knowhow agreement with Mayo Clinic to develop a new generation of premium supplements
BGM Group LtdMr Xin Zhanchang Chairman of the Board of Directors of BGM Group and Chairman of Gansu Qilianshan Pharmaceutical Co Ltd led the sales team to visit their longterm strategic partner Jointown Pharmaceutical Group
Astellas Pharma Incand Sangamo Therapeutics Inc Nasdaq SGMO a genomic medicine company today announced they have entered into a license agreement allowing Astellas to leverage Sangamos novel proprietary neurotropic
Everest Medicines a biopharmaceutical company focused on the discovery clinical development manufacturing and commercialization of innovative therapeutics today announced that the first prescription for VELSIPITY
